Integrated Cannabis Solutions, Inc. (IGPK)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Integrated Cannabis Solutions, Inc. (IGPK) with AI Score 60/100 (Hold). Integrated Cannabis Solutions, Inc. focuses on the cultivation and processing of hemp biomass in the United States. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 17, 2026Integrated Cannabis Solutions, Inc. (IGPK) Healthcare & Pipeline Overview
Integrated Cannabis Solutions, Inc. (IGPK) cultivates and processes hemp biomass for CBD extraction, targeting manufacturers in the specialty and generic drug sector. With a small team and a focus on establishing a consistent biomass supply, IGPK operates in the evolving cannabis-derived products market, facing competition and regulatory uncertainties.
Investment Thesis
Integrated Cannabis Solutions, Inc. (IGPK) operates in the nascent and evolving CBD market. The company's strategy focuses on supplying CBD and isolate to manufacturers. Key value drivers include establishing a reliable biomass supply through a co-op model and securing long-term purchase contracts. The company's small size and limited resources present challenges. The company's P/E ratio is 9.15, with a profit margin of 1.2% and a gross margin of 3.3%. The company's success hinges on navigating regulatory hurdles and establishing strong relationships with manufacturers. Upcoming catalysts include the potential establishment of the farmer's co-op and securing long-term supply contracts. Potential risks include competition from larger players and fluctuating CBD prices.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.00B indicates the company's small size and early stage of development.
- P/E ratio of 9.15 suggests the company is generating earnings, but this should be viewed with caution given the micro-cap status and potential volatility.
- Profit margin of 1.2% and gross margin of 3.3% indicate low profitability and potential challenges in cost management.
- Beta of 0.16 suggests the stock is significantly less volatile than the overall market.
- The company does not offer a dividend, which is common for growth-oriented companies in emerging sectors.
Competitors & Peers
Strengths
- Focus on the growing CBD market.
- Plans to establish a consistent biomass supply.
- Strategic location in Coconut Creek, Florida.
- Low beta indicates lower volatility than the market.
Weaknesses
- Small size and limited resources (1 employee).
- Low profit margin and gross margin.
- Dependence on external manufacturers for product distribution.
- OTC listing indicates higher risk and lower liquidity.
Catalysts
- Ongoing: Potential establishment of a co-op with local farmers to ensure a consistent supply of biomass.
- Ongoing: Securing long-term purchase contracts with farmers for biomass supply.
- Upcoming: Expansion into new CBD product categories.
- Upcoming: Geographic expansion within the United States.
- Upcoming: Development of proprietary CBD extraction technologies.
Risks
- Ongoing: Evolving and uncertain regulatory landscape for CBD products.
- Ongoing: Intense competition from larger players in the CBD market.
- Ongoing: Fluctuations in CBD prices affecting profitability.
- Potential: Changes in consumer preferences for CBD products.
- Potential: Limited financial resources hindering growth and expansion.
Growth Opportunities
- Expansion into New CBD Product Categories: IGPK can expand its product offerings beyond CBD and isolate to include other cannabis-derived compounds and formulations. The global cannabidiol (CBD) market was valued at $6.86 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 16.2% from 2024 to 2032. This expansion could involve developing proprietary extraction methods or partnering with manufacturers to create unique CBD products, potentially increasing revenue streams and market share.
- Geographic Expansion within the United States: IGPK can expand its operations to new states within the United States that have favorable cannabis regulations. As more states legalize cannabis for medical and recreational use, the demand for CBD products is expected to increase. The company can establish partnerships with local farmers and manufacturers in these states to create a geographically diverse supply chain and tap into new markets. This expansion can mitigate risks associated with regulatory changes in specific states.
- Development of Proprietary CBD Extraction Technologies: Investing in research and development to create proprietary CBD extraction technologies can provide IGPK with a competitive advantage. More efficient extraction methods can reduce production costs, improve product quality, and increase the yield of CBD from hemp biomass. This can lead to higher profit margins and a stronger market position. The timeline for developing and implementing these technologies may range from 1 to 3 years.
- Strategic Partnerships with Pharmaceutical Companies: IGPK can pursue strategic partnerships with pharmaceutical companies to supply CBD and isolate for use in pharmaceutical products. As research into the therapeutic benefits of CBD continues, pharmaceutical companies may seek to incorporate CBD into their product lines. Securing long-term supply agreements with these companies can provide IGPK with a stable revenue stream and access to a larger market. The timeline for establishing these partnerships may vary depending on the pharmaceutical company's research and development plans.
- Establishment of a Vertically Integrated Business Model: IGPK can expand its operations to include the manufacturing and distribution of its own CBD products. This vertically integrated approach can increase profit margins and provide greater control over the supply chain. The company can develop its own brand of CBD products and market them directly to consumers through online channels and retail partnerships. The timeline for establishing a vertically integrated business model may range from 2 to 5 years.
Opportunities
- Expansion into new CBD product categories.
- Geographic expansion within the United States.
- Development of proprietary CBD extraction technologies.
- Strategic partnerships with pharmaceutical companies.
Threats
- Evolving and uncertain regulatory landscape.
- Intense competition from larger players.
- Fluctuations in CBD prices.
- Potential changes in consumer preferences.
Competitive Advantages
- Focus on establishing a consistent biomass supply through a co-op model.
- Long-term purchase contracts with local farmers.
- Specialization in CBD and isolate production.
About IGPK
Integrated Cannabis Solutions, Inc., originally founded in 2003 as Integrated Parking Solutions, shifted its focus to the cannabis industry in April 2014. Headquartered in Coconut Creek, Florida, the company cultivates and processes hemp or biomass within the United States. IGPK's primary business model centers around producing and selling processed hemp material, specifically Cannabidiol (CBD) and isolate. These materials are intended for manufacturers and pharmaceutical companies that produce and distribute CBD-related products. These products include edibles, vitamins, topical creams, oils, tinctures, salves, and vaping liquids. IGPK plans to establish a co-op with local farmers to ensure a consistent supply of biomass. The company intends to enter into long-term purchase contracts with these farmers. With a small team of one employee, IGPK operates in a competitive market with evolving regulations. The company's success depends on securing reliable biomass sources, efficient processing, and establishing strong relationships with manufacturers in the CBD product space.
What They Do
- Grows and processes hemp or biomass in the United States.
- Produces Cannabidiol (CBD) and isolate from hemp.
- Sells processed CBD material to manufacturers and pharmaceutical companies.
- Supplies CBD for use in edibles, vitamins, and topical products.
- Aims to establish a co-op with local farmers for consistent biomass supply.
- Plans to enter into long-term purchase contracts with farmers.
Business Model
- Cultivates and processes hemp biomass.
- Extracts CBD and isolate from the biomass.
- Sells CBD and isolate to manufacturers of CBD products.
Industry Context
Integrated Cannabis Solutions, Inc. operates within the Drug Manufacturers - Specialty & Generic industry, specifically focusing on the cannabis-derived CBD market. This market is characterized by rapid growth, evolving regulations, and increasing consumer demand for CBD products. The industry is highly competitive, with numerous players ranging from large pharmaceutical companies to smaller, specialized producers. IGPK's strategy of supplying CBD and isolate positions it within the supply chain, targeting manufacturers of finished CBD products. The company faces competition from established players and must navigate regulatory complexities to succeed.
Key Customers
- Manufacturers of CBD edibles for human consumption.
- Pharmaceutical companies producing CBD-based products.
- Manufacturers of CBD-infused vitamins and multi-vitamins.
- Companies that produce topical CBD products like creams, oils, and salves.
- Manufacturers of CBD vaping liquids.
Financials
Chart & Info
Integrated Cannabis Solutions, Inc. (IGPK) stock price: Price data unavailable
Latest News
No recent news available for IGPK.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for IGPK.
Price Targets
Wall Street price target analysis for IGPK.
MoonshotScore
What does this score mean?
The MoonshotScore rates IGPK's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Eugene L. Caiazzo
Unknown
Information on Eugene L. Caiazzo's background is limited. He currently manages Integrated Cannabis Solutions, Inc., which has a single employee. Further details regarding his prior experience, education, or credentials are not available in the provided data.
Track Record: Due to limited information, Eugene L. Caiazzo's track record at Integrated Cannabis Solutions, Inc. cannot be fully assessed. The company's shift from Integrated Parking Solutions to Integrated Cannabis Solutions occurred in 2014. Specific achievements or strategic decisions under his leadership are not detailed in the provided data.
IGPK OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Integrated Cannabis Solutions, Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQB or OTCQX. Companies in this tier often have limited operating history, lower trading volume, and may be subject to less regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ. Investors should exercise caution and conduct thorough due diligence before investing in companies on the OTC Other tier.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure due to OTC Other tier status.
- Low trading volume and liquidity.
- Higher potential for price manipulation.
- Increased regulatory scrutiny and compliance risks.
- Potential for delisting or suspension from trading.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's capitalization structure and potential dilution risks.
- Review the company's legal and regulatory compliance.
- Monitor the company's trading volume and price volatility.
- Consult with a qualified financial advisor before investing.
- Company's operational focus on the growing CBD market.
- Plans to establish a co-op with local farmers.
- Existence of a physical headquarters in Coconut Creek, Florida.
- Company's history dating back to 2003 (as Integrated Parking Solutions).
What Investors Ask About Integrated Cannabis Solutions, Inc. (IGPK)
What does Integrated Cannabis Solutions, Inc. do?
Integrated Cannabis Solutions, Inc. cultivates and processes hemp or biomass in the United States, focusing on extracting Cannabidiol (CBD) and isolate. The company aims to supply these processed materials to manufacturers and pharmaceutical companies for use in various CBD-related products, including edibles, vitamins, topical creams, and vaping liquids. IGPK also plans to establish a co-op with local farmers to ensure a consistent supply of biomass, which is crucial for maintaining a stable production process and meeting market demand.
What are the key growth opportunities for IGPK in healthcare?
Integrated Cannabis Solutions, Inc. can expand its product offerings beyond CBD and isolate to include other cannabis-derived compounds and formulations. The company can explore strategic partnerships with pharmaceutical companies to supply CBD and isolate for use in pharmaceutical products. As research into the therapeutic benefits of CBD continues, pharmaceutical companies may seek to incorporate CBD into their product lines. Securing long-term supply agreements with these companies can provide IGPK with a stable revenue stream and access to a larger market.
What are the main risks for IGPK?
Integrated Cannabis Solutions, Inc. faces several risks, including the evolving and uncertain regulatory landscape for CBD products, which can impact its ability to operate and sell its products. The company also faces intense competition from larger players in the CBD market, which can put pressure on prices and margins. Fluctuations in CBD prices can also affect the company's profitability. Additionally, changes in consumer preferences for CBD products and limited financial resources can hinder growth and expansion.
What revenue streams does Integrated Cannabis Solutions, Inc. have in healthcare?
Integrated Cannabis Solutions, Inc.'s primary revenue stream is the sale of processed hemp material, specifically Cannabidiol (CBD) and isolate, to manufacturers and pharmaceutical companies. These manufacturers then use these materials to produce a variety of CBD-related products, such as edibles for human consumption, vitamins, multi-vitamins, and topical products for human use comprises oils, tinctures, creams, oils and salves, and vaping liquids. The company's revenue is dependent on securing contracts with these manufacturers and maintaining a consistent supply of high-quality CBD and isolate.
What are the competitive advantages of Integrated Cannabis Solutions, Inc.?
Integrated Cannabis Solutions, Inc.'s competitive advantages include its focus on establishing a consistent biomass supply through a co-op model with local farmers, which can provide a stable and cost-effective source of raw materials. The company's specialization in CBD and isolate production allows it to focus on a specific segment of the cannabis market and develop expertise in this area. Additionally, the company's plans to enter into long-term purchase contracts with farmers can provide a predictable supply chain and reduce the risk of price fluctuations.
What are the key factors to evaluate for IGPK?
Integrated Cannabis Solutions, Inc. (IGPK) currently holds an AI score of 60/100, indicating moderate score. Key strength: Focus on the growing CBD market.. Primary risk to monitor: Ongoing: Evolving and uncertain regulatory landscape for CBD products.. This is not financial advice.
How frequently does IGPK data refresh on this page?
IGPK prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven IGPK's recent stock price performance?
Recent price movement in Integrated Cannabis Solutions, Inc. (IGPK) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Focus on the growing CBD market.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on the company's financials and operations.
- OTC listing indicates higher risk and lower liquidity.
- Small market capitalization and limited trading volume.